anicells

Active

Private limited company (pre-2019)founded 2019active for 7 yearsGalileilaan 21, 2845 Niel, BelgiumKBO/BCE: BE 0725.459.634

From the official registers: KBO 7 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

anicells has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €184,634 and a net result of €79,113. Equity is growing by about 66% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow Report Compare

anicellsActiveChecked score 88/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 17-04-2019 Normal situation
Legal form: Private limited company (pre-2019)
Registered office: Galileilaan 21, 2845 Niel
Activity: Research and development on biotechnology NACE 72101and 1 other
Establishment unit: 2.289.395.186 2845 Niel, since 17-04-2019
Financial year end: 31 March
Peppol: Reachable since 21-10-2026

Company details

Who decides

Board

Cools NathalieDirector

Board & ownership

How it is doing

88 Excellent Checked score 2026

Bankruptcy probabilitywithin 12 months: 0.2%

Annual accounts to 31-03-2026

Gross margin: €1.2m; ▲ 25.7%
Turnover: ≈ €2.1m; estimated
Profit: €79,113; ▲ 48.4%
Equity: €184,634; ▲ 75.0%
Total assets: €1.8m; ▲ 0.7%
Staff: 13.8 FTE; ▲ 25.5%

2026 accounts 16 days early

Filed on 15-10-2026at the National Bank

Financials

Why 88raises riskEquity €184,634 (10.1% of total assets)lowers riskSector: Scientific research and development (NACE 72)Liquidity: current ratio 1.05, cash €570,573Figures for financial year 2026 (filed 20-10-2026)Show the evidence

Checked score

Score 2026

88 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 59% of its sector peers (NACE 72, small)

Every signal that counts is listed under Signals.

Financial strength · tick = 2025

Strong

Solvency 35+4

equity 10.1% of total assets

Liquidity 71+6

short-term debt 38.3% · cash 31.3%

Profitability 74+2

return on assets 4.3%

Bankruptcy probability, 12 months

0.2% Very low

0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (165 companies, NACE 72, small)

Last 24 months 11-2024: 0.1%lowest value 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.2%▲ +0.1 percentage points vs 09-2025 11-2025: 0.1%▼ -0.1 percentage points vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.2%▲ +0.1 percentage points vs 09-2026highest value

Credit of up to €16,000 on 30-day terms is acceptable

Liquidity tight (current ratio 1.05, compared with 1.18 in 2025, below the usual 1.5; short-term debt: 38.3% and cash: 31.3% of total assets), and 89.9% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, small): better than 17% on solvency, 70% on liquidity, 65% on profitability and 86% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises riskneutral

Sector: Scientific research and development (NACE 72)

KBO

Liquidity: current ratio 1.05, cash €570,573

NBB · annual accounts

Equity €184,634 (10.1% of total assets)

NBB · annual accounts

Figures for financial year 2026 (filed 20-10-2026)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 15-10-2026, 16 days ahead of the deadline.

NBB · 7 filings

Deviation from the deadline

2026

16 days early

2025

17 days early

2024

22 days early

2023

33 days early

2022

3 days late

2021

31 days early

2020

30 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 12 days before the deadline; the sector median (NACE 72) for financial year 2024 is 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 14 October (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-03-2027 year end31-10-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: Equity rose in 2026from €105,520 to €184,634 ▲ 75.0% View
Positive: 6 profitable years in a rowprofit 2026: €79,113 6 years View
Flemish supportawarded from 2024 to 2025 €399,910 View
Positive: Filed on time since financial year 2023accounts within the deadline every year 4 years View

Documents

Key facts about anicells

What is the company number of anicells?: 0725.459.634. In Belgium the VAT number is the company number with BE in front: BE 0725.459.634.
Where is anicells based?: The registered office is at Galileilaan 21, 2845 Niel.Company details
What does anicells do?: According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of anicells?: Private limited company (pre-2019) (BVBA).
When was anicells founded?: On 17-04-2019.
Is anicells still active?: Yes, anicells is an active enterprise in the KBO register.
How many employees does anicells have?: On average 13.8 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
What is the turnover of anicells?: ≈ €2.1m in financial year 2026. Estimated from the gross margin of €1.2m: probably between €1.4m and €3.5m, based on 1,587 comparable companies of the same size. A rough estimate.
Is anicells profitable?: In financial year 2026, anicells made a profit of €79,113.
Where can I find the annual accounts of anicells?: anicells filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2026.Annual accounts at the National Bank
When are the next annual accounts of anicells due?: By 31-10-2027, for financial year 2027.Timeline